CYP3A4 and cardiac arrhythmia: For instance, astemizole, a drug for the treatment of allergic symptoms, was withdrawn from the market due to the possibility of prolongation of the QT interval and arrhythmias when combined with cytochrome P450 3A4 (CYP3A4) inhibitors, including grapefruit juice and erythromycin1.